A modern obstetrician-gynecologists' view on the multivitamin complexes for pregnant women
DOI:
https://doi.org/10.18370/2309-4117.2019.47.64-67Keywords:
pregnancy, dietary supplement, micronutrients, deficiency, Pregnа-5Abstract
During pregnancy, especially in the second and third trimesters, the need of pregnant woman's body for plastic and biologically active substances, which are later used to build the fetus organs and systems, significantly increases. The lack of certain vitamins, minerals and trace elements during pregnancy negatively affects the health of women and fetus, thereby increasing the risk of perinatal pathology and infant mortality, as well as the frequency of prematurity, congenital malformations, disorders of physical and mental child development. Milk secretion during lactation also contributes to the gradual depletion of vitamins and minerals in the woman body.
Completing the lack of certain vitamins and microelements during pregnancy by additional unbalanced food intake, which contains the necessary micronutrients, is usually accompanied by an excessive increase in weight and increase in fetal weight, which leads to birth trauma and other complications. Therefore, even a balanced diet of a pregnant woman cannot fully satisfy her needs for vitamins and trace elements. Therefore, the use of dietary supplements during pregnancy and lactation is extremely necessary for every woman.
The most favorable and rational solution to prevent the micronutrient deficiencies is the regular use of special dietary supplements for pregnant women, which include the dietary supplement Pregna-5 from Amaxa Pharma. Its feature and the main difference from other drugs of this group, presented in Ukraine, that it contains exactly those nutrients, which recommended amount is difficult to obtain with balanced diet. Pregna-5 contains ω-3 polyunsaturated fatty acid (specifically docosohexaenoic acid) in a dosage of 250 μg. Also this drug contains vitamin D3 (cholecalciferol) – 2000 MI, iodine – 200 mg, folates – 800 mg, iron – 30 mg.
References
- Reveiz, L., Gyte, G.M.L., Cuervo, L.G., Casasbuenas, A. “Treatments for iron-deficiency anaemia in pregnancy (Review).” Cochrane Library (2011).
- Friedman, A.J., et al. “Iron deficiency anemia in women across the life span.” Journal of women’s health 21 (2012): 1282–9.
- Pietrzik, K., et al. “Folic Acid and L-5-Methyltetrahydrofolate Compression of clinical pharmacokinetics and pharmacodynamics.” Clin Pharmacokinetic 49.8 (2010).
- Zhivoglazova, L.N., Kurmacheva, N.A., et al. “Effectiveness of the prevention of micronutrient deficiencies in pregnant women and newborns.” Saratov Journal of Medical Scientific Researches 6.2 (2010): 300–6.
- Gromova, O.A. Vitamins and minerals in pregnant and lactating women. Methodical letter for clinicians. Moscow. RCS of International Institute of Micronutrients UNESCO (2007): 140 p.
- Dawodu, A., Saadi, H.F., Bekdache, G., et al. “A randomized controlled trial of vitamin D intake during pregnancy with widespread vitamin D deficiency.” J Clin Endocrinol Metab 98 (2013): 2337–46.
- Kurmacheva, N.A., Borisova, N.V., et al. “Micronutrient and thyroid status of pregnant women in iodine deficiency region depending on the diet and type of iodine prophylaxis.” Gynecology 7.1 (2005): 13–17.
- Nisevich, L.L., Adieva, A.A., et al. “Preconceptional preparation of women for pregnancy and its impact on the fetus and child health.” Pediatric Pharmacology 5.6 (2008): 45–51.
- Pyrohova, V.I., Shurpiak, S.O., et al. “On the issue of prevention of complicated pregnancy during insufficiency and deficiency of vitamin D.” Woman’s Health 6 (2016): 19–27.
- Dvoretskiy, L.I. “Clinical recommendations for the treatment of iron deficiency anemia.” Russian Medical Journal (2004).
- Makrides, M., Duley, L., Olsen, S.F. “Marine oil, and other prostaglandin precursor, supplementation for pregnancy uncomplicated by pre-eclampsia or intrauterine growth restriction.” Cochrane Database Syst Rev 3 (2006): CD003402.
- Moskalchuk, L.V. “Hygienic estimation of folic acid supply to the adult population of Ukraine.” Environment & Health 2 (2014): 37–40.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2019 О. В. Булавенко, О. В. Фурман, О. А. Таран, О. Л. Льовкіна
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.